NASDAQ:OSUR - OraSure Technologies Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$16.21 +0.13 (+0.81 %)
(As of 05/25/2018 04:00 PM ET)
Previous Close$16.21
Today's Range$15.9050 - $16.22
52-Week Range$12.86 - $23.01
Volume545,481 shs
Average Volume686,643 shs
Market Capitalization$981.91 million
P/E Ratio31.78
Dividend YieldN/A
Beta1.69

About OraSure Technologies (NASDAQ:OSUR)

OraSure Technologies logoOraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, OSUR and DNAG. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Its principal products include OraQuick ADVANCE HIV-1/2, OraQuick HIV?1/2, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV, OraQuick Ebola, OraQuick Zika, OraSure QuickFlu Rapid Flu A&B test, OraSure, Oragene DX, Oragene DNA, Oragene RNA, ORAcollect DX, ORAcollect DNA, OMNIgene DISCOVER, Performagene, OMNIgene GUT, OMNIgene SPUTUM, OMNIgene VAGINAL, OMNIgene ORAL, GenoFIND, Hemagene, PrepIT, GenoFIND, Intercept, MICRO-PLATE DOA assays, Intercept i2, homogeneous DOA assays, and professional and over-the-counter cryosurgical systems. In addition, the company manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. Further, it provides medical devices for the removal of benign skin lesions by cryosurgery or freezing; immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot HIV-1 confirmatory test for confirming positive HIV-1 test; and Q.E.D. rapid point-of-care saliva alcohol test. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, retail pharmacies, mass merchandisers, and consumers. OraSure Technologies, Inc. was founded in 1979 and is based in Bethlehem, Pennsylvania.

Receive OSUR News and Ratings via Email

Sign-up to receive the latest news and ratings for OSUR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:OSUR
CUSIP68554V10
Phone610-882-1820

Debt

Debt-to-Equity RatioN/A
Current Ratio9.29
Quick Ratio8.30

Price-To-Earnings

Trailing P/E Ratio31.78
Forward P/E Ratio52.29
P/E Growth4.22

Sales & Book Value

Annual Sales$167.06 million
Price / Sales5.92
Cash Flow$0.6208 per share
Price / Cash26.11
Book Value$4.24 per share
Price / Book3.82

Profitability

EPS (Most Recent Fiscal Year)$0.51
Net Income$30.94 million
Net Margins9.28%
Return on Equity6.58%
Return on Assets5.84%

Miscellaneous

Employees377
Outstanding Shares61,060,000

OraSure Technologies (NASDAQ:OSUR) Frequently Asked Questions

What is OraSure Technologies' stock symbol?

OraSure Technologies trades on the NASDAQ under the ticker symbol "OSUR."

How were OraSure Technologies' earnings last quarter?

OraSure Technologies (NASDAQ:OSUR) posted its quarterly earnings results on Wednesday, May, 2nd. The medical instruments supplier reported ($0.03) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.06) by $0.03. The medical instruments supplier had revenue of $41.99 million for the quarter, compared to analyst estimates of $40.53 million. OraSure Technologies had a return on equity of 6.58% and a net margin of 9.28%. The business's quarterly revenue was up 29.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.21 EPS. View OraSure Technologies' Earnings History.

When is OraSure Technologies' next earnings date?

OraSure Technologies is scheduled to release their next quarterly earnings announcement on Tuesday, July, 31st 2018. View Earnings Estimates for OraSure Technologies.

What price target have analysts set for OSUR?

3 Wall Street analysts have issued 1 year price targets for OraSure Technologies' shares. Their forecasts range from $19.00 to $24.00. On average, they anticipate OraSure Technologies' share price to reach $22.00 in the next year. View Analyst Ratings for OraSure Technologies.

Who are some of OraSure Technologies' key competitors?

Who are OraSure Technologies' key executives?

OraSure Technologies' management team includes the folowing people:
  • Mr. Douglas A. Michels, Pres, CEO & Director (Age 61)
  • Mr. Ronald H. Spair, CFO, COO & Director (Age 62)
  • Dr. Michael Reed Ph.D., Chief Science Officer and Sr. VP of R&D (Age 49)
  • Mr. Jack E. Jerrett, Sr. VP, Gen. Counsel & Sec. (Age 59)
  • Mr. Anthony Zezzo II, Exec. VP & Bus. Unit Leader of Infectious Disease (Age 64)

Has OraSure Technologies been receiving favorable news coverage?

Media stories about OSUR stock have trended somewhat positive on Saturday, according to Accern Sentiment. The research firm identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. OraSure Technologies earned a coverage optimism score of 0.12 on Accern's scale. They also assigned media coverage about the medical instruments supplier an impact score of 46.80 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Who are OraSure Technologies' major shareholders?

OraSure Technologies' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.47%), Dimensional Fund Advisors LP (4.61%), Northern Trust Corp (1.23%), Intrinsic Edge Capital Management LLC (1.22%), Fisher Asset Management LLC (0.97%) and Wells Fargo & Company MN (0.94%). Company insiders that own OraSure Technologies stock include Anthony Zezzo II, Brian Smith, Charles W Patrick, Douglas A Michels, Jack E Jerrett, Mara G Aspinall, Mark L Kuna, Michael Celano, Ronald H Spair, Ronny B Lancaster and Stephen S Phd Tang. View Institutional Ownership Trends for OraSure Technologies.

Which institutional investors are selling OraSure Technologies stock?

OSUR stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Intrinsic Edge Capital Management LLC, Mckinley Capital Management LLC Delaware, JPMorgan Chase & Co., Allianz Asset Management GmbH, Allianz Asset Management GmbH, Dimensional Fund Advisors LP and BlackRock Inc.. Company insiders that have sold OraSure Technologies company stock in the last year include Anthony Zezzo II, Brian Smith, Charles W Patrick, Douglas A Michels, Jack E Jerrett, Ronald H Spair, Ronny B Lancaster and Stephen S Phd Tang. View Insider Buying and Selling for OraSure Technologies.

Which institutional investors are buying OraSure Technologies stock?

OSUR stock was acquired by a variety of institutional investors in the last quarter, including Chatham Capital Group Inc., WINTON GROUP Ltd, A.R.T. Advisors LLC, Trexquant Investment LP, Virginia Retirement Systems ET AL, Alambic Investment Management L.P., Barclays PLC and Quantbot Technologies LP. View Insider Buying and Selling for OraSure Technologies.

How do I buy shares of OraSure Technologies?

Shares of OSUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is OraSure Technologies' stock price today?

One share of OSUR stock can currently be purchased for approximately $16.21.

How big of a company is OraSure Technologies?

OraSure Technologies has a market capitalization of $981.91 million and generates $167.06 million in revenue each year. The medical instruments supplier earns $30.94 million in net income (profit) each year or $0.51 on an earnings per share basis. OraSure Technologies employs 377 workers across the globe.

How can I contact OraSure Technologies?

OraSure Technologies' mailing address is 220 EAST FIRST STREET, BETHLEHEM PA, 18015. The medical instruments supplier can be reached via phone at 610-882-1820 or via email at [email protected]


MarketBeat Community Rating for OraSure Technologies (OSUR)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  375 (Vote Outperform)
Underperform Votes:  216 (Vote Underperform)
Total Votes:  591
MarketBeat's community ratings are surveys of what our community members think about OraSure Technologies and other stocks. Vote "Outperform" if you believe OSUR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OSUR will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

OraSure Technologies (NASDAQ:OSUR) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for OraSure Technologies in the last 12 months. Their average twelve-month price target is $22.00, suggesting that the stock has a possible upside of 35.72%. The high price target for OSUR is $24.00 and the low price target for OSUR is $19.00. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.672.672.80
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $22.00$22.00$22.00$17.25
Price Target Upside: 35.72% upside2.09% upside2.09% upside12.66% downside

OraSure Technologies (NASDAQ:OSUR) Consensus Price Target History

Price Target History for OraSure Technologies (NASDAQ:OSUR)

OraSure Technologies (NASDAQ:OSUR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/2/2018Canaccord GenuityReiterated RatingBuy$24.00LowView Rating Details
11/2/2017Jefferies GroupDowngradeBuy ➝ HoldN/AView Rating Details
7/11/2017StephensReiterated RatingOverweight$14.00 ➝ $19.00LowView Rating Details
2/9/2017Raymond JamesUpgradeMarket Perform ➝ Outperform$11.25N/AView Rating Details
12/20/2016CL KingInitiated CoverageBuy$11.00N/AView Rating Details
9/19/2016BTIG ResearchDowngradeBuy ➝ Neutral$8.00N/AView Rating Details
7/5/2016MizuhoReiterated RatingOutperform$8.00N/AView Rating Details
(Data available from 5/26/2016 forward)

Earnings

OraSure Technologies (NASDAQ:OSUR) Earnings History and Estimates Chart

Earnings by Quarter for OraSure Technologies (NASDAQ:OSUR)

OraSure Technologies (NASDAQ:OSUR) Earnings Estimates

2018 EPS Consensus Estimate: $0.28
2019 EPS Consensus Estimate: $0.53
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.06)($0.06)($0.06)
Q2 20181$0.04$0.04$0.04
Q3 20181$0.10$0.10$0.10
Q4 20181$0.20$0.20$0.20
Q1 20191$0.11$0.11$0.11
Q2 20191$0.12$0.12$0.12
Q3 20191$0.12$0.12$0.12
Q4 20191$0.18$0.18$0.18

OraSure Technologies (NASDAQ OSUR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/31/2018$0.04N/AView Earnings Details
5/2/2018Q1 2018($0.06)($0.03)$40.53 million$41.99 millionViewListenView Earnings Details
2/7/2018Q4 2017$0.11$0.12$50.20 million$52.00 millionViewListenView Earnings Details
11/1/2017Q3 2017$0.09$0.09$40.87 million$42.30 millionViewN/AView Earnings Details
8/2/2017Q2 2017$0.07$0.09$36.54 million$40.18 millionViewListenView Earnings Details
5/3/2017Q1 2017$0.17$0.21$31.19 million$32.55 millionViewListenView Earnings Details
2/8/2017Q4 2016$0.06$0.13$34.80 million$35.50 millionViewListenView Earnings Details
11/2/2016Q316$0.07$0.11$31.45 million$32.25 millionViewListenView Earnings Details
8/3/2016Q216$0.05$0.07$31.15 million$31.36 millionViewListenView Earnings Details
5/4/2016Q1$0.02$0.04$28.82 million$29.10 millionViewListenView Earnings Details
2/3/2016Q4$0.03$0.08$29.73 million$32.38 millionViewListenView Earnings Details
11/4/2015Q315($0.01)$0.03$29.58 million$29.90 millionViewListenView Earnings Details
8/5/2015Q215$0.01$0.03$28.95 million$30.34 millionViewListenView Earnings Details
2/4/2015Q414($0.04)($0.05)$28.22 million$28.68 millionViewListenView Earnings Details
11/5/2014Q314($0.05)$0.02$27.20 million$27.85 millionViewListenView Earnings Details
8/6/2014Q214($0.04)$0.04$26.21 million$26.40 millionViewListenView Earnings Details
5/7/2014Q114($0.13)($0.10)$23.28 million$23.50 millionViewListenView Earnings Details
2/5/2014Q413($0.08)$0.11$27.43 million$28.80 millionViewListenView Earnings Details
11/6/2013Q313($0.10)($0.03)$24.21 million$24.70 millionViewListenView Earnings Details
8/7/2013Q2 2013($0.16)($0.10)$23.67 million$24.30 millionViewListenView Earnings Details
5/8/2013Q1 2013($0.18)($0.18)$20.82 million$21.20 millionViewListenView Earnings Details
2/6/2013Q4 2012($0.14)($0.11)$20.87 million$22.14 millionViewListenView Earnings Details
11/7/2012Q312($0.07)($0.04)$22.26 million$22.10 millionViewN/AView Earnings Details
8/7/2012($0.08)($0.07)ViewN/AView Earnings Details
5/2/2012($0.09)($0.07)ViewN/AView Earnings Details
2/8/2012Q4 2011($0.07)$0.02ViewN/AView Earnings Details
11/2/2011($0.07)($0.03)ViewN/AView Earnings Details
8/3/2011($0.05)($0.05)ViewN/AView Earnings Details
5/5/2011($0.08)($0.06)ViewN/AView Earnings Details
2/9/2011($0.08)($0.02)ViewN/AView Earnings Details
11/9/2010Q3 2010($0.04)$0.01ViewN/AView Earnings Details
8/4/2010Q2 2010($0.08)($0.01)ViewN/AView Earnings Details
5/5/2010Q1 2010($0.06)($0.05)ViewN/AView Earnings Details
2/10/2010Q4 2009($0.08)($0.03)ViewN/AView Earnings Details
11/4/2009Q3 2009($0.05)$0.04ViewN/AView Earnings Details
8/5/2009Q2 2009($0.07)($0.05)ViewN/AView Earnings Details
5/6/2009Q1 2009($0.07)($0.04)ViewN/AView Earnings Details
2/11/2009Q4 2008($0.10)($0.07)ViewN/AView Earnings Details
11/5/2008Q3 2008($0.11)($0.04)ViewN/AView Earnings Details
8/5/2008Q2 2008($0.08)($0.05)ViewN/AView Earnings Details
5/6/2008Q1 2008$0.03$0.04ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

OraSure Technologies (NASDAQ:OSUR) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

OraSure Technologies (NASDAQ OSUR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.90%
Institutional Ownership Percentage: 92.17%
Insider Trading History for OraSure Technologies (NASDAQ:OSUR)
Institutional Ownership by Quarter for OraSure Technologies (NASDAQ:OSUR)

OraSure Technologies (NASDAQ OSUR) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/16/2018Brian SmithEVPSell20,000$17.97$359,400.0028,075View SEC Filing  
2/15/2018Stephen S Phd TangDirectorSell23,333$17.97$419,294.0159,749View SEC Filing  
11/7/2017Mara G AspinallDirectorBuy5,000$14.23$71,150.005,000View SEC Filing  
10/4/2017Douglas A MichelsCEOSell22,923$23.00$527,229.00View SEC Filing  
9/29/2017Douglas A MichelsCEOSell25,000$22.55$563,750.00743,058View SEC Filing  
8/31/2017Brian SmithInsiderSell9,112$20.47$186,522.6432,477View SEC Filing  
8/30/2017Charles W PatrickDirectorSell1,000$20.11$20,110.0051,104View SEC Filing  
8/22/2017Brian SmithInsiderSell3,075$21.09$64,851.7524,540View SEC Filing  
8/7/2017Anthony Zezzo IIEVPSell72,916$21.26$1,550,194.16218,326View SEC Filing  
8/7/2017Jack E JerrettSVPSell73,463$20.77$1,525,826.5181,593View SEC Filing  
8/7/2017Ronald H SpairCFOSell510,112$20.66$10,538,913.92208,606View SEC Filing  
6/27/2017Douglas A MichelsCEOSell290,495$16.75$4,865,791.25894,012View SEC Filing  
5/30/2017Ronny B LancasterDirectorSell89,684$14.79$1,326,426.366,295View SEC Filing  
5/10/2017Anthony Zezzo IIEVPSell115,000$14.70$1,690,500.00260,410View SEC Filing  
5/9/2017Douglas A MichelsCEOSell209,800$15.01$3,149,098.00782,025View SEC Filing  
5/8/2017Douglas A MichelsCEOSell361,216$15.08$5,447,137.28881,620View SEC Filing  
5/8/2017Mark L KunaSVPSell36,413$15.11$550,200.4392,904View SEC Filing  
5/8/2017Ronald H SpairCFOSell72,564$15.00$1,088,460.00175,130View SEC Filing  
5/5/2017Michael CelanoDirectorSell44,962$14.95$672,181.9038,117View SEC Filing  
3/21/2017Stephen S Phd TangDirectorSell220$12.00$2,640.0031,748View SEC Filing  
2/28/2017Charles W PatrickDirectorSell29,883$11.29$337,379.0774,959View SEC Filing  
2/16/2017Ronald H SpairCFOSell50,000$11.12$556,000.00View SEC Filing  
2/15/2017Jack E JerrettSVPSell107,288$11.06$1,186,605.2880,842View SEC Filing  
2/15/2017Stephen S Phd TangDirectorSell40,000$11.04$441,600.0078,068View SEC Filing  
2/14/2017Ronald H SpairCFOSell63,720$10.60$675,432.00169,860View SEC Filing  
2/10/2017Mark L KunaSVPSell79,271$10.61$841,065.3163,491View SEC Filing  
1/31/2017Michael CelanoDirectorSell15,000$8.78$131,700.00108,079View SEC Filing  
1/17/2017Ronald H SpairCFOSell3,341$8.71$29,100.11106,663View SEC Filing  
12/15/2016Mark L KunaSVPSell10,000$9.30$93,000.0082,965View SEC Filing  
12/13/2016Douglas A MichelsCEOSell71,466$9.07$648,196.62747,114View SEC Filing  
12/13/2016Mark L KunaSVPSell17,000$9.11$154,870.0084,965View SEC Filing  
12/9/2016Mark L KunaSVPSell3,000$9.03$27,090.0075,965View SEC Filing  
11/23/2016Douglas A MichelsCEOSell30,893$9.02$278,654.86731,898View SEC Filing  
11/23/2016Jack E JerrettSVPSell24,000$9.00$216,000.0060,105View SEC Filing  
9/26/2016Douglas A MichelsCEOSell25,000$8.22$205,500.00756,898View SEC Filing  
8/31/2016Charles W PatrickDirectorSell17,483$8.58$150,004.1477,209View SEC Filing  
8/30/2016Jack E JerrettSVPSell68,686$8.52$585,204.7286,441View SEC Filing  
8/29/2016Charles W PatrickDirectorSell2,250$8.94$20,115.0077,209View SEC Filing  
8/5/2016Charles W PatrickDirectorSell6,575$7.24$47,603.0077,209View SEC Filing  
12/19/2014Ronald H SpairCFOSell75,974$10.01$760,499.74View SEC Filing  
12/9/2014Ronald H SpairCFOSell1,026$10.00$10,260.00View SEC Filing  
12/8/2014Ronald H SpairCFOSell126$10.00$1,260.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

OraSure Technologies (NASDAQ OSUR) News Headlines

Source:
DateHeadline
OraSure Technologies to Present at the UBS Global Healthcare Conference   OraSure Technologies to Present at the UBS Global Healthcare Conference   
finance.yahoo.com - May 14 at 10:05 AM
OraSure Technologies (OSUR) Receives Average Recommendation of "Hold" from BrokeragesOraSure Technologies (OSUR) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - May 13 at 3:35 PM
Jefferies Group Comments on OraSure Technologies FY2018 Earnings (OSUR)Jefferies Group Comments on OraSure Technologies' FY2018 Earnings (OSUR)
www.americanbankingnews.com - May 7 at 3:44 AM
ValuEngine Lowers OraSure Technologies (OSUR) to HoldValuEngine Lowers OraSure Technologies (OSUR) to Hold
www.americanbankingnews.com - May 5 at 1:13 AM
Reviewing InVivo Therapeutics (NVIV) & OraSure Technologies (OSUR)Reviewing InVivo Therapeutics (NVIV) & OraSure Technologies (OSUR)
www.americanbankingnews.com - May 4 at 3:29 PM
OraSure Technologies (OSUR) Downgraded by TheStreetOraSure Technologies (OSUR) Downgraded by TheStreet
www.americanbankingnews.com - May 4 at 3:17 PM
OraSure Technologies to Post Q1 2019 Earnings of $0.11 Per Share, Jefferies Group Forecasts (OSUR)OraSure Technologies to Post Q1 2019 Earnings of $0.11 Per Share, Jefferies Group Forecasts (OSUR)
www.americanbankingnews.com - May 4 at 10:15 AM
New finance chief at OraSureNew finance chief at OraSure
seekingalpha.com - May 4 at 9:15 AM
OraSure Technologies Appoints New Chief Financial OfficerOraSure Technologies Appoints New Chief Financial Officer
finance.yahoo.com - May 4 at 9:15 AM
Traders Buy Large Volume of OraSure Technologies Call Options (OSUR)Traders Buy Large Volume of OraSure Technologies Call Options (OSUR)
www.americanbankingnews.com - May 4 at 8:50 AM
OraSure Technologies (OSUR) Issues Quarterly  Earnings ResultsOraSure Technologies (OSUR) Issues Quarterly Earnings Results
www.americanbankingnews.com - May 3 at 5:38 PM
OraSure Technologies (OSUR) CEO Stephen Tang on Q1 2018 Results - Earnings Call TranscriptOraSure Technologies' (OSUR) CEO Stephen Tang on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 3 at 9:12 AM
OraSure: 1Q Earnings SnapshotOraSure: 1Q Earnings Snapshot
finance.yahoo.com - May 3 at 9:12 AM
Edited Transcript of OSUR earnings conference call or presentation 2-May-18 9:00pm GMTEdited Transcript of OSUR earnings conference call or presentation 2-May-18 9:00pm GMT
finance.yahoo.com - May 3 at 9:12 AM
OraSure Technologies beats by $0.03, beats on revenueOraSure Technologies beats by $0.03, beats on revenue
seekingalpha.com - May 2 at 4:38 PM
OraSure Announces 2018 First Quarter Financial ResultsOraSure Announces 2018 First Quarter Financial Results
finance.yahoo.com - May 2 at 4:38 PM
OraSure Technologies (OSUR) Rating Increased to Hold at Zacks Investment ResearchOraSure Technologies (OSUR) Rating Increased to Hold at Zacks Investment Research
www.americanbankingnews.com - May 2 at 12:52 PM
Global Influenza Market to Reach $6.5 billion by 2022Global Influenza Market to Reach $6.5 billion by 2022
globenewswire.com - April 24 at 4:47 PM
Market Trends Toward New Normal in Healthways, Global Net Lease, OraSure Technologies, Lions Gate ...Market Trends Toward New Normal in Healthways, Global Net Lease, OraSure Technologies, Lions Gate ...
globenewswire.com - April 24 at 4:47 PM
OraSure Technologies (OSUR) Lowered to Sell at Zacks Investment ResearchOraSure Technologies (OSUR) Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - April 24 at 8:58 AM
OraSure Technologies (OSUR) to Release Quarterly Earnings on TuesdayOraSure Technologies (OSUR) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - April 24 at 4:38 AM
OraSure Technologies (OSUR) Receives Average Recommendation of "Hold" from AnalystsOraSure Technologies (OSUR) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - April 18 at 3:26 PM
OraSure Technologies (OSUR) Downgraded by Zacks Investment ResearchOraSure Technologies (OSUR) Downgraded by Zacks Investment Research
www.americanbankingnews.com - April 18 at 10:05 AM
OraSure Technologies (OSUR) Downgraded by BidaskClubOraSure Technologies (OSUR) Downgraded by BidaskClub
www.americanbankingnews.com - April 16 at 5:24 PM
OraSure Technologies (OSUR) Downgraded to "Hold" at BidaskClubOraSure Technologies (OSUR) Downgraded to "Hold" at BidaskClub
www.americanbankingnews.com - April 14 at 9:51 PM
OraSure Technologies Appoints New Senior Vice President, Business DevelopmentOraSure Technologies Appoints New Senior Vice President, Business Development
finance.yahoo.com - April 10 at 4:35 PM
$40.55 Million in Sales Expected for OraSure Technologies (OSUR) This Quarter$40.55 Million in Sales Expected for OraSure Technologies (OSUR) This Quarter
www.americanbankingnews.com - April 9 at 2:36 AM
OraSure Technologies (OSUR) "Buy" Rating Reaffirmed at Jefferies GroupOraSure Technologies' (OSUR) "Buy" Rating Reaffirmed at Jefferies Group
www.americanbankingnews.com - April 8 at 11:55 PM
Zacks: Brokerages Expect OraSure Technologies (OSUR) Will Announce Earnings of -$0.06 Per ShareZacks: Brokerages Expect OraSure Technologies (OSUR) Will Announce Earnings of -$0.06 Per Share
www.americanbankingnews.com - April 7 at 3:13 PM
OraSure Technologies (OSUR) Raised to Buy at Zacks Investment ResearchOraSure Technologies (OSUR) Raised to Buy at Zacks Investment Research
www.americanbankingnews.com - April 5 at 5:46 PM
BidaskClub Downgrades OraSure Technologies (OSUR) to HoldBidaskClub Downgrades OraSure Technologies (OSUR) to Hold
www.americanbankingnews.com - April 3 at 11:00 AM
OraSure Technologies (OSUR) Lowered to Hold at Jefferies GroupOraSure Technologies (OSUR) Lowered to Hold at Jefferies Group
www.americanbankingnews.com - April 2 at 8:19 AM
Edited Transcript of OSUR earnings conference call or presentation 7-Feb-18 10:00pm GMTEdited Transcript of OSUR earnings conference call or presentation 7-Feb-18 10:00pm GMT
finance.yahoo.com - April 1 at 9:25 AM
BidaskClub Lowers OraSure Technologies (OSUR) to BuyBidaskClub Lowers OraSure Technologies (OSUR) to Buy
www.americanbankingnews.com - March 28 at 11:00 AM
OraSure Technologies, Inc. (OSUR) Given Average Recommendation of "Buy" by AnalystsOraSure Technologies, Inc. (OSUR) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - March 24 at 3:36 PM
OraSure Technologies, Inc. (OSUR) Expected to Post Quarterly Sales of $40.55 MillionOraSure Technologies, Inc. (OSUR) Expected to Post Quarterly Sales of $40.55 Million
www.americanbankingnews.com - March 23 at 4:36 AM
OraSure Technologies (OSUR) Upgraded to Strong-Buy by BidaskClubOraSure Technologies (OSUR) Upgraded to Strong-Buy by BidaskClub
www.americanbankingnews.com - March 17 at 5:00 PM
Free Research Reports on These Medical Supplies Stocks -- OraSure Technologies, Precision Therapeutics, Tandem Diabetes Care, and TransEnterixFree Research Reports on These Medical Supplies Stocks -- OraSure Technologies, Precision Therapeutics, Tandem Diabetes Care, and TransEnterix
www.bizjournals.com - March 16 at 9:38 AM
OraSure Technologies (OSUR) Presents At Raymond James 39th Annual Institutional Investors Conference - SlideshowOraSure Technologies (OSUR) Presents At Raymond James 39th Annual Institutional Investors Conference - Slideshow
seekingalpha.com - March 6 at 4:54 PM
 Analysts Anticipate OraSure Technologies, Inc. (OSUR) Will Post Quarterly Sales of $40.55 Million Analysts Anticipate OraSure Technologies, Inc. (OSUR) Will Post Quarterly Sales of $40.55 Million
www.americanbankingnews.com - March 6 at 12:13 PM
Credit Agricole S A Sells 20,000 Shares of OraSure Technologies, Inc. (OSUR)Credit Agricole S A Sells 20,000 Shares of OraSure Technologies, Inc. (OSUR)
www.americanbankingnews.com - March 4 at 5:38 AM
OraSure Technologies (OSUR) Upgraded at ValuEngineOraSure Technologies (OSUR) Upgraded at ValuEngine
www.americanbankingnews.com - March 3 at 3:22 PM
OraSure Technologies (OSUR) versus Neurometrix (NURO) Critical SurveyOraSure Technologies (OSUR) versus Neurometrix (NURO) Critical Survey
www.americanbankingnews.com - March 2 at 1:39 PM
Arrowstreet Capital Limited Partnership Invests $7.58 Million in OraSure Technologies, Inc. (OSUR)Arrowstreet Capital Limited Partnership Invests $7.58 Million in OraSure Technologies, Inc. (OSUR)
www.americanbankingnews.com - March 2 at 4:33 AM
OraSure Technologies, Inc. (OSUR) Receives Consensus Rating of "Buy" from BrokeragesOraSure Technologies, Inc. (OSUR) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - February 27 at 5:36 PM
Comerica Bank Decreases Position in OraSure Technologies, Inc. (OSUR)Comerica Bank Decreases Position in OraSure Technologies, Inc. (OSUR)
www.americanbankingnews.com - February 27 at 6:02 AM
Systematic Financial Management LP Has $1.72 Million Stake in OraSure Technologies, Inc. (OSUR)Systematic Financial Management LP Has $1.72 Million Stake in OraSure Technologies, Inc. (OSUR)
www.americanbankingnews.com - February 25 at 11:30 AM
OraSure Technologies, Inc. (OSUR) Director Sells $419,294.01 in StockOraSure Technologies, Inc. (OSUR) Director Sells $419,294.01 in Stock
www.americanbankingnews.com - February 20 at 6:56 PM
Brian Smith Sells 20,000 Shares of OraSure Technologies, Inc. (OSUR) StockBrian Smith Sells 20,000 Shares of OraSure Technologies, Inc. (OSUR) Stock
www.americanbankingnews.com - February 20 at 6:56 PM
BidaskClub Downgrades OraSure Technologies (OSUR) to BuyBidaskClub Downgrades OraSure Technologies (OSUR) to Buy
www.americanbankingnews.com - February 17 at 10:28 PM

SEC Filings

OraSure Technologies (NASDAQ:OSUR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

OraSure Technologies (NASDAQ:OSUR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

OraSure Technologies (NASDAQ OSUR) Stock Chart for Saturday, May, 26, 2018

Loading chart…

This page was last updated on 5/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.